Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

ClinicalTrials.gov ID: NCT00467259

Public ClinicalTrials.gov record NCT00467259. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-controlled, Multicenter, 52-week Study to Evaluate the Endometrial Safety of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women With Hypoactive Sexual Desire Disorder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to evaluate the endometrial safety of a testosterone patch as treatment for low libido in naturally postmenopausal women.

Study identification

NCT ID
NCT00467259
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
1,271 participants

Conditions and interventions

Eligibility (public fields only)

Age range
45 Years to 70 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2007 (Type not available)
Primary completion
Jan 2009 (Actual)
Completion
Jan 2009 (Actual)
Last update posted
Dec 15, 2011

2007 – 2009

United States locations

U.S. sites
115
U.S. states
36
U.S. cities
100
Facility City State ZIP Site status
Study Facility Birmingham Alabama 35209 —
Research Facility Birmingham Alabama 35233 —
Research Facility Mobile Alabama 36617 —
Research Facility Montgomery Alabama 36116 —
Test Facility Chandler Arizona 85225 —
Study Facility Peoria Arizona 85381 —
Research Facility Phoenix Arizona 85015 —
Research Facility Phoenix Arizona 85032 —
Research Facility Scottsdale Arizona 85251 —
Research Site Tucson Arizona 85712 —
Research Facility Tucson Arizona 85715 —
Study Facility Tuscon Arizona 85741 —
Site Facility Jonesboro Arkansas 72401 —
Site Facility Little Rock Arkansas 72223 —
Research Facility Anaheim California 92805 —
Research Site Berkeley California 94705 —
Research Facility Palm Desert California 92260 —
Research Facility Pasadena California 91106 —
Research Facility San Diego California 92123 —
Research Facility San Ramon California 94583 —
Test Facility Santa Rosa California 95405 —
Site Facility Upland California 91786 —
Research Facility Vista California 92083 —
Site Facility Vista California 92083 —
Site Facility Westlake Village California 91361 —
Test Facility Denver Colorado 80218 —
Research Facility Longmont Colorado 80501 —
Test Facility New London Connecticut 06320 —
Study Facility Waterbury Connecticut 06708 —
Research Facility Washington D.C. District of Columbia 20036 —
Research Facility Boynton Beach Florida 33437 —
Site Facility Clearwater Florida 33759 —
Site Facility Daytona Beach Florida 32114 —
Research Facility Gainesville Florida 32601 —
Research Site Jacksonville Florida 32207 —
Site Facility Jupiter Florida 33458 —
Test Facility Miami Florida 33156 —
Research Facility Pinellas Park Florida 33781 —
Research Facility Plantation Florida 33324 —
Study Facility South Miami Florida 33143 —
Research Site Tampa Florida 33606 —
Test Facility Vero Beach Florida 32960 —
Research Facility West Palm Beach Florida 33409 —
Research Facility Weston Florida 33326 —
Research Facility Alpharetta Georgia 30005 —
Research Facility Atlanta Georgia 30342 —
Site Facility Decatur Georgia 30034 —
Site Facility Douglasville Georgia 30134 —
Site Facility Roswell Georgia 30075 —
Test Facility Savannah Georgia 31405 —
Study Facility Idaho Falls Idaho 83404 —
Test Facility Champaign Illinois 61820 —
Test Facility Chicago Illinois 60610 —
Test Facility Indianapolis Indiana 46250 —
Research Facility Overland Park Kansas 66202 —
Site Facility Louisville Kentucky 40291 —
Study Facility Baltimore Maryland 21229 —
Research Facility Baltimore Maryland 21285-6815 —
Study Facility Boston Massachusetts 02114 —
Research Facility Bingham Farm Michigan 48025 —
Study Facility Paw Paw Michigan 49079 —
Test Facility Saginaw Michigan — —
Research Facility Edina Minnesota 55435 —
Research Site Jackson Mississippi 39216 —
Test Facility St Louis Missouri 63141 —
Site Facility Billings Montana 59102 —
Research Site Omaha Nebraska 68124 —
Site Facility Las Vegas Nevada 89146 —
Test Facility Reno Nevada 89502 —
Test Facility Moorestown New Jersey 08057 —
Research Facility New York New York 10016 —
Test Facility Raleigh North Carolina 27609 —
Site Facility Winston-Salem North Carolina 27103 —
Study Facility Winston-Salem North Carolina 27103 —
Research Facility Beachwood Ohio 44122 —
Test Facility Centerville Ohio 45459 —
Research Facility Cincinnati Ohio 45219 —
Study Facility Cincinnati Ohio 45249 —
Research Facility Cincinnati Ohio 45267-0457 —
Research Site Cleveland Ohio 44106 —
Site Facility Cleveland Ohio 44122 —
Test Facility Columbus Ohio 43212 —
Test Facility Columbus Ohio 43231 —
Research Facility Dayton Ohio 45409 —
Test Facility Englewood Ohio 45322 —
Test Facility Oklahoma City Oklahoma — —
Test Facility Tulsa Oklahoma 74104 —
Site Facility Eugene Oregon 97401 —
Research Facility Philadelphia Pennsylvania 19114 —
Study Facility Bristol Tennessee 37620 —
Research Facility Chattanooga Tennessee 37404 —
Research Facility Nashville Tennessee 37203 —
Site Facility Austin Texas 78705 —
Research Facility Carrolton Texas 75007 —
Site Facility Corpus Christi Texas 78414 —
Research Facility Dallas Texas 75231 —
Test Facility Farmers Branch Texas 75234 —
Research Facility Houston Texas 77030 —
Research Facility Irving Texas 75061 —
Research Facility Midland Texas 79705 —
Research Facility Richardson Texas 75082 —
Site Facility San Antonio Texas 78229 —
Test Facility San Antonio Texas 78229 —
Study Facility Salt Lake City Utah 84117 —
Research Facility West Valley City Utah 84120 —
Research Facility Newport News Virginia 23606 —
Study Facility Richmond Virginia 23229 —
Test Facility Richmond Virginia 23229 —
Site Facility Richmond Virginia 23294 —
Research Facility Virginia Beach Virginia 23452 —
Research Facility Virginia Beach Virginia 23456 —
Site Facility Seattle Washington 98105 —
Research Facility Tacoma Washington 98405 —
Test Facility Tacoma Washington 98405 —
Research Site Charleston West Virginia 25301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00467259, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2011 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00467259 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →